These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16449549

  • 1. Erythropoietin dose requirements when converting from subcutaneous to intravenous administration among patients on hemodialysis.
    Moist LM, Muirhead N, Wazny LD, Gallo KL, Heidenheim AP, House AA.
    Ann Pharmacother; 2006 Feb; 40(2):198-203. PubMed ID: 16449549
    [Abstract] [Full Text] [Related]

  • 2. Conversion from subcutaneous to intravenous erythropoietin in a hemodialysis population.
    Vercaigne LM, Collins DM, Penner SB.
    J Clin Pharmacol; 2005 Aug; 45(8):895-900. PubMed ID: 16027399
    [Abstract] [Full Text] [Related]

  • 3. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F, David S, Sala P, Icardi A, Casani A.
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Feb 17; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM, Gutiérrez MJ, Sánchez G, Kornhauser C.
    Rev Invest Clin; 1996 Feb 17; 48(3):173-7. PubMed ID: 8966377
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.
    Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA.
    N Engl J Med; 1998 Aug 27; 339(9):578-83. PubMed ID: 9718376
    [Abstract] [Full Text] [Related]

  • 13. Effect of switching from subcutaneous to intravenous administration of epoetin-alpha in haemodialysis patients: results from a Swedish multicentre survey.
    Linde T, Furuland H, Wikström B.
    Scand J Urol Nephrol; 2005 Aug 27; 39(4):329-33. PubMed ID: 16118109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
    Crit Care Med; 2006 Sep 27; 34(9):2310-6. PubMed ID: 16878035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J.
    Clin Exp Pharmacol Physiol; 2007 Apr 27; 34(4):347-9. PubMed ID: 17324148
    [Abstract] [Full Text] [Related]

  • 20. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.
    G Ital Nefrol; 2002 Apr 27; 19(5):552-9. PubMed ID: 12439845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.